Depomed Acquires U.S. Rights to Late-Stage, First-in-Class Pain Product from Grunenthal
November 17, 2015 at 16:26 PM EST
Depomed, Inc. (NASDAQ: DEPO) today announced that it has entered into a definitive agreement to acquire the U.S. and Canadian rights to ...